Drug treatment in bronchial asthma.
D000111:Acetylcysteine / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001249:Asthma / Q000150:complications / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002110:Caffeine / Q000627:therapeutic use; D004338:Drug Combinations; D004809:Ephedrine / Q000627:therapeutic use; D004837:Epinephrine / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006140:Guaifenesin / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications; D007545:Isoproterenol / Q000009:adverse effects / Q000627:therapeutic use; D009093:Mucus / Q000187:drug effects; D013566:Sympathomimetics / Q000008:administration & dosage / Q000627:therapeutic use*; D013806:Theophylline / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D004338:Drug Combinations; D005100:Expectorants; D005938:Glucocorticoids; D013566:Sympathomimetics; D014970:Xanthines; D002110:Caffeine; D006140:Guaifenesin; D013806:Theophylline; D004809:Ephedrine; D007545:Isoproterenol; D000111:Acetylcysteine; D004837:Epinephrine